Results 161 to 170 of about 75,166 (219)

An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond. [PDF]

Vaccines (Basel)
McIntyre P, van den Biggelaar AHJ, Beard F, Nowlan M, Regan AK, Pearce R, Nolan T, Hughes C, Richmond P.   +8 more
europepmc   +1 more source

Editorial: Vaccine and infectious disease informatics. [PDF]

Front Cell Infect Microbiol
Hur J, Cao Z, Petrovsky N, Brusic V, Tao C, He Y.   +5 more
europepmc   +1 more source

Population waning trajectories of vaccine-induced tetanus immunity in Zhejiang, China. [PDF]

Front Immunol
Chen F, Zhou Y, Zhu Y, Pan X, Ding L, He H, Qi X.   +6 more
europepmc   +1 more source

Failure of tetanus immunoglobulin prophylaxis: a case report. [PDF]

World J Emerg Med
Du W, Lai L, Wang C, Lan P.
europepmc   +1 more source

Associations of prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and childhood vaccine-induced immunity. [PDF]

Environ Health
Smith A, Lin PD, Rifas-Shiman SL, Gold DR, Hivert MF, Oken E, Cardenas A.   +6 more
europepmc   +1 more source

Non-Wound Tetanus Mimicking Botulism in a Low-Resource Setting: Early Recognition and Successful Intensive Care Management. [PDF]

Int Med Case Rep J
Elmi AH, Abdi AO.
europepmc   +1 more source

Single-dose dual-indication nanoparticle vaccine co-displaying <i>Pseudomonas aeruginosa</i> antigen and tetanus toxin fragment confers durable protection against mixed exposure. [PDF]

Mater Today Bio
Zhu Z, Yan J, Wan J, Wu M, Liao Z, Peng X, Wang Y, Li Y, Wang Y, Liu X, Wang B, Zou Q, Zhu J, Gu J.   +13 more
europepmc   +1 more source

Pharmacist Prescribing as a Strategy to Facilitate Vaccine Accessibility in Ontario, Canada. [PDF]

Pharmacy (Basel)
Houle SKD.
europepmc   +1 more source

Rehabilitation Strategy Guided by Physiological Indicators in a Patient With Tetanus and Multiple Fractures: A Case Report. [PDF]

Cureus
Kon T, Matsumoto A, Sasamoto Y.
europepmc   +1 more source